These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7808734

  • 21. Decreased platelet vesicular monoamine transporter density in children and adolescents with attention deficit/hyperactivity disorder.
    Toren P, Rehavi M, Luski A, Roz N, Laor N, Lask M, Weizman A.
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):159-62. PubMed ID: 15695060
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Decreased platelet vesicular monoamine transporter density in habitual smokers.
    Schwartz K, Weizman A, Rehavi M.
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):235-8. PubMed ID: 15695071
    [Abstract] [Full Text] [Related]

  • 26. Increased ventral striatal monoaminergic innervation in Tourette syndrome.
    Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA.
    Neurology; 2003 Aug 12; 61(3):310-5. PubMed ID: 12913189
    [Abstract] [Full Text] [Related]

  • 27. Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains.
    Kilbourn M, Frey K.
    Eur J Pharmacol; 1996 Jun 27; 307(2):227-32. PubMed ID: 8832225
    [Abstract] [Full Text] [Related]

  • 28. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.
    Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K.
    Eur J Pharmacol; 1995 Dec 29; 294(2-3):577-83. PubMed ID: 8750721
    [Abstract] [Full Text] [Related]

  • 29. In vivo imaging of the brain vesicular monoamine transporter.
    Vander Borght TM, Kilbourn MR, Koeppe RA, DaSilva JN, Carey JE, Kuhl DE, Frey KA.
    J Nucl Med; 1995 Dec 29; 36(12):2252-60. PubMed ID: 8523116
    [Abstract] [Full Text] [Related]

  • 30. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
    Staal RG, Hogan KA, Liang CL, German DC, Sonsalla PK.
    J Pharmacol Exp Ther; 2000 May 29; 293(2):329-35. PubMed ID: 10772999
    [Abstract] [Full Text] [Related]

  • 31. In vivo binding of (+)-alpha-[3H]dihydrotetrabenazine to the vesicular monoamine transporter of rat brain: bolus vs. equilibrium studies.
    Kilbourn M, Sherman P.
    Eur J Pharmacol; 1997 Jul 23; 331(2-3):161-8. PubMed ID: 9274975
    [Abstract] [Full Text] [Related]

  • 32. Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography.
    Gilman S, Koeppe RA, Adams KM, Junck L, Kluin KJ, Johnson-Greene D, Martorello S, Heumann M, Bandekar R.
    Ann Neurol; 1998 Sep 23; 44(3):326-33. PubMed ID: 9749598
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Time required for transmitter accumulation inside monoaminergic storage vesicles differs in peripheral and in central systems.
    Scherman D, Boschi G.
    Neuroscience; 1988 Dec 23; 27(3):1029-35. PubMed ID: 3252170
    [Abstract] [Full Text] [Related]

  • 35. Characterization of the vesicular monoamine transporter in cultured rat sympathetic neurons: persistence upon induction of cholinergic phenotypic traits.
    Scherman D, Weber MJ.
    Dev Biol; 1987 Jan 23; 119(1):68-74. PubMed ID: 3792636
    [Abstract] [Full Text] [Related]

  • 36. Functional identification and molecular cloning of a human brain vesicle monoamine transporter.
    Erickson JD, Eiden LE.
    J Neurochem; 1993 Dec 23; 61(6):2314-7. PubMed ID: 8245983
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Vesicular monoamine transporters heterologously expressed in the yeast Saccharomyces cerevisiae display high-affinity tetrabenazine binding.
    Yelin R, Schuldiner S.
    Biochim Biophys Acta; 2001 Feb 09; 1510(1-2):426-41. PubMed ID: 11342177
    [Abstract] [Full Text] [Related]

  • 39. Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles.
    Cesura AM, Bertocci B, Da Prada M.
    Eur J Pharmacol; 1990 Sep 04; 186(1):95-104. PubMed ID: 2149340
    [Abstract] [Full Text] [Related]

  • 40. [3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity.
    Vander Borght TM, Sima AA, Kilbourn MR, Desmond TJ, Kuhl DE, Frey KA.
    Neuroscience; 1995 Oct 04; 68(3):955-62. PubMed ID: 8577387
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.